Literature DB >> 18929579

Generation of reactive oxygen species during mouse hepatic microsomal metabolism of cannabidiol and cannabidiol hydroxy-quinone.

Noriyuki Usami1, Ikuo Yamamoto, Kazuhito Watanabe.   

Abstract

We investigated whether cannabidiol (CBD) and cannabidiol hydroxy-quinone (CBDHQ) generate reactive oxygen species (ROS) during metabolism with mouse hepatic microsomes. CBD and CBDHQ (91.5 microM) significantly suppressed lipid peroxidation in the mouse hepatic microsomes. CBDHQ also significantly decreased NADH-cytochrome b5 reductase (fp1) activity by 25% of the control activity in the hepatic microsomes, and tended to increase NADPH-cytochrome c (P450) reductase (fp2) activity. CBDHQ also significantly inhibited superoxide dismutase and catalase activities in mouse hepatic 105,000 xg supernatant. Moreover, CBDHQ significantly increased glutathione reductase activity and significantly inhibited NAD(P)H-quinone reductase activity. CBD exhibited similar effects on these enzymes, except that cannabinoid significantly inhibited glutathione reductase activity in mouse hepatic 105,000 xg supernatant. These results suggest that CBDHQ is easily converted to the semiquinone form rather than the hydroquinone form. It was also suggested that CBDHQ and CBD were capable of generating ROS as superoxide anion radicals during their metabolism with mouse hepatic microsomes or with purified fp2 by electron spin resonance spin trapping methods with 5,5-dimethyl-1-pyrroline-N-oxide. The present results suggest that CBDHQ formed during hepatic microsomal metabolism of CBD is capable of generating ROS and inducing cell toxicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18929579     DOI: 10.1016/j.lfs.2008.09.011

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

Review 1.  Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

Authors:  Javier Fernández-Ruiz; Onintza Sagredo; M Ruth Pazos; Concepción García; Roger Pertwee; Raphael Mechoulam; José Martínez-Orgado
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

2.  Comparison between cannabidiol and sertraline for the modulation of post-traumatic stress disorder-like behaviors and fear memory in mice.

Authors:  Xiao Han; Xiankui Song; Dake Song; Guanbo Xie; Hongyan Guo; Ning Wu; Jin Li
Journal:  Psychopharmacology (Berl)       Date:  2022-04-09       Impact factor: 4.530

Review 3.  Molecular Targets of Cannabidiol in Neurological Disorders.

Authors:  Clementino Ibeas Bih; Tong Chen; Alistair V W Nunn; Michaël Bazelot; Mark Dallas; Benjamin J Whalley
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

4.  Cannabidiol Promotes Endothelial Cell Survival by Heme Oxygenase-1-Mediated Autophagy.

Authors:  Sabine Böckmann; Burkhard Hinz
Journal:  Cells       Date:  2020-07-16       Impact factor: 6.600

Review 5.  Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review.

Authors:  Judy Trac; J Myles Keck; Joseph E Deweese
Journal:  J Cannabis Res       Date:  2021-04-23

6.  New Insights on Hemp Oil Enriched in Cannabidiol: Decarboxylation, Antioxidant Properties and In Vitro Anticancer Effect.

Authors:  Anca Roxana Petrovici; Natalia Simionescu; Andreea Isabela Sandu; Vasile Paraschiv; Mihaela Silion; Mariana Pinteala
Journal:  Antioxidants (Basel)       Date:  2021-05-07

7.  Up-regulation of heme oxygenase-1 expression and inhibition of disease-associated features by cannabidiol in vascular smooth muscle cells.

Authors:  Margit Schwartz; Sabine Böckmann; Burkhard Hinz
Journal:  Oncotarget       Date:  2018-10-02

8.  Hepatotoxicity of a Cannabidiol-Rich Cannabis Extract in the Mouse Model.

Authors:  Laura E Ewing; Charles M Skinner; Charles M Quick; Stefanie Kennon-McGill; Mitchell R McGill; Larry A Walker; Mahmoud A ElSohly; Bill J Gurley; Igor Koturbash
Journal:  Molecules       Date:  2019-04-30       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.